Fluorescent in situ hybridization (FISH) in the differential diagnosis of ground-glass opacities in the lung

Lung Cancer

Volumn 71, Issue 3, 2011, Pages 319-322

  Bettio, Daniela ^a   Venci, Anna ^a   Cariboni, Umberto ^a   Di Rocco, Mariagrazia ^a   Infante, Maurizio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Cytogenetics; FISH; Ground glass opacity; Lung

Indexed keywords

MOLECULAR MARKER;

ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER RELAPSE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL;

HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79851510404     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.06.014     Document Type: Article

References (12)

1. Infante M., Lutman R.F., Imparato S., Di Rocco M., Ceresoli G.L., Torri V., et al. Differential diagnosis and management of focal ground-glass opacities. Eur Resp J 2009, 33:1-7.
2. Henschke C.I., Yankelevitz D.F., Mirtcheva R., McGuinness G., McCauley D., Miettinen O.S. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178:1053-1057. ELCAP Group.
3. Nakata M., Saeki H., Takata I., Segawa Y., Mogami H., Mandai K., et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002, 121:1464-1467.
4. Kitamura H., Kameda Y., Ito T., Hayashi H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 1999, 111:610-622.
5. Travis W., Colby T., Corrin B., Shimosato Y., Brambilla E., Sobin L.H. World health organization: histological typing of lung and pleural tumors 1999, Springer, Berlin, pp. 28-40.
6. Bettio D., Giardino D., Rizzi N., Simoni G. Cytogenetic abnormalities detected by direct analysis in a case of choriocarcinoma. Cancer Genet Cytogenet 1993, 68:149-151.
7. Bettio D., Rizzi N., Giardino D., Persani L., Pecori-Giraldi F., Losa M., et al. Cytogenetic study of pituitary adenomas. Cancer Genet Cytogenet 1997, 98:131-136.
8. Shaffer L.G., Tommerup N. ISCN 2005: an international system for human cytogenetic nomenclature 2005, S. Karger, Basel.
9. Sokolova I.A., Bubendorf L., O'Hare A., Legator M.S., Jacobson K.K., Grilli B.S.B., et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer 2002, 96:306-315.
10. Halling K.C., Rickman O.B., Kipp B.R., Harwood A.R., Doerr C.H., Jett J.R. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 2006, 130:694-701.
11. Beasley M., Brambilla E., Travis W. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005, 40:90-97.
12. Williams B.R., Amon A. Aneuploidy: cancer's fatal flaw?. Cancer Res 2009, 69:5289-5291.